Henk Nab

877 total citations
31 papers, 660 citations indexed

About

Henk Nab is a scholar working on Rheumatology, Oncology and Pathology and Forensic Medicine. According to data from OpenAlex, Henk Nab has authored 31 papers receiving a total of 660 indexed citations (citations by other indexed papers that have themselves been cited), including 18 papers in Rheumatology, 9 papers in Oncology and 8 papers in Pathology and Forensic Medicine. Recurrent topics in Henk Nab's work include Systemic Lupus Erythematosus Research (16 papers), Rheumatoid Arthritis Research and Therapies (13 papers) and Global Cancer Incidence and Screening (7 papers). Henk Nab is often cited by papers focused on Systemic Lupus Erythematosus Research (16 papers), Rheumatoid Arthritis Research and Therapies (13 papers) and Global Cancer Incidence and Screening (7 papers). Henk Nab collaborates with scholars based in United States, United Kingdom and Netherlands. Henk Nab's co-authors include J.W.W. Coebergh, L.H. van der Heijden, Edward R. Hammond, Ron Pedersen, Barnabas Desta, B Freundlich, A. J. Taggart, M. Gaubitz, Piet L. C. M. van Riel and J Sany and has published in prestigious journals such as Annals of the Rheumatic Diseases, European Journal of Cancer and Lara D. Veeken.

In The Last Decade

Henk Nab

30 papers receiving 643 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Henk Nab United States 15 399 191 157 153 105 31 660
A. Nzeusseu Toukap Belgium 14 549 1.4× 226 1.2× 114 0.7× 144 0.9× 121 1.2× 36 784
DT Boumpas Greece 14 544 1.4× 383 2.0× 94 0.6× 78 0.5× 93 0.9× 25 1.1k
F M Lai Hong Kong 15 286 0.7× 177 0.9× 45 0.3× 101 0.7× 113 1.1× 30 874
Bozena Möller Sweden 9 678 1.7× 471 2.5× 203 1.3× 72 0.5× 74 0.7× 12 962
K. D. Watson United Kingdom 3 519 1.3× 244 1.3× 58 0.4× 160 1.0× 115 1.1× 3 724
Larissa Lisnevskaia Canada 6 505 1.3× 394 2.1× 68 0.4× 47 0.3× 111 1.1× 8 738
Allen R. Hendricks United States 8 600 1.5× 446 2.3× 79 0.5× 45 0.3× 102 1.0× 16 913
David Musselman United States 9 878 2.2× 339 1.8× 174 1.1× 307 2.0× 116 1.1× 16 1.3k
A. Krabben Netherlands 18 684 1.7× 110 0.6× 81 0.5× 165 1.1× 73 0.7× 26 862
Jared Hassler United States 5 601 1.5× 448 2.3× 69 0.4× 51 0.3× 106 1.0× 7 898

Countries citing papers authored by Henk Nab

Since Specialization
Citations

This map shows the geographic impact of Henk Nab's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Henk Nab with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Henk Nab more than expected).

Fields of papers citing papers by Henk Nab

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Henk Nab. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Henk Nab. The network helps show where Henk Nab may publish in the future.

Co-authorship network of co-authors of Henk Nab

This figure shows the co-authorship network connecting the top 25 collaborators of Henk Nab. A scholar is included among the top collaborators of Henk Nab based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Henk Nab. Henk Nab is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Lin, Dora H., Irene B. Murimi, Hong Kan, et al.. (2022). Health care utilization and costs of systemic lupus erythematosus in the United States: A systematic review. Lupus. 31(7). 773–807. 6 indexed citations
2.
Schwarting, Andreas, Marc Pignot, Xia Wang, et al.. (2021). The Burden of Systemic Lupus Erythematosus in Germany: Incidence, Prevalence, and Healthcare Resource Utilization. Rheumatology and Therapy. 8(1). 375–393. 31 indexed citations
3.
Murimi, Irene B., Dora H. Lin, Henk Nab, et al.. (2020). Association between organ damage and mortality in systemic lupus erythematosus: a systematic review and meta-analysis. BMJ Open. 10(5). e031850–e031850. 63 indexed citations
4.
Hammond, Edward R., H. Kan, Jonothan C. Tierce, et al.. (2017). SAT0227 Health care utilization and costs of systemic lupus erythematosus (SLE) in the united states: systematic review. Annals of the Rheumatic Diseases. 76. 859–860. 4 indexed citations
5.
Fleischmann, Roy, Andrew Koenig, Annette Szumski, et al.. (2014). Short-term efficacy of etanercept plus methotrexate vs combinations of disease-modifying anti-rheumatic drugs with methotrexate in established rheumatoid arthritis. Lara D. Veeken. 53(11). 1984–1993. 13 indexed citations
6.
Emery, Paul, Gaia Gallo, Helen Boyd, et al.. (2014). Association between disease activity and risk of serious infections in subjects with rheumatoid arthritis treated with etanercept or disease-modifying anti-rheumatic drugs.. PubMed. 32(5). 653–60. 19 indexed citations
7.
Bae, Sang‐Cheol, Chi Chiu Mok, Rezaul Karim Khandker, et al.. (2013). Improved health outcomes with Etanercept versus usual DMARD therapy in an Asian population with established rheumatoid arthritis. BMC Musculoskeletal Disorders. 14(1). 13–13. 38 indexed citations
8.
Kirkham, Bruce, et al.. (2013). The Importance Of Managing Arthritis In Patients With Both Moderate-To-Severe Psoriasis And Psoriatic Arthritis. Value in Health. 16(3). A227–A227. 1 indexed citations
9.
Kim, Ho‐Youn, Ping‐Ning Hsu, Debbie Robertson, et al.. (2011). Randomized comparison of etanercept with usual therapy in an Asian population with active rheumatoid arthritis: the APPEAL trial. International Journal of Rheumatic Diseases. 15(2). 188–196. 30 indexed citations
10.
FitzGerald, Oliver, Philip Helliwell, Philip J. Mease, et al.. (2011). Application of composite disease activity scores in psoriatic arthritis to the PRESTA data set. Annals of the Rheumatic Diseases. 71(3). 358–362. 51 indexed citations
11.
Linden, Paul D. van der, et al.. (2001). Fluoroquinolone use and the change in incidence of tendon ruptures in the Netherlands.. Pharmacy World & Science. 23(3). 89–92. 20 indexed citations
12.
Hendriks, J.H.C.L., et al.. (1997). Do non-specific minimal signs in a biennial mammographic breast cancer screening programme need further diagnostic assessment?. British Journal of Radiology. 70(829). 34–38. 37 indexed citations
13.
Voogd, Adri C., Henk Nab, M.A. Crommelin, et al.. (1996). Comparison of breast-conserving therapy with mastectomy for treatment of early breast cancer in community hospitals. European Journal of Surgical Oncology. 22(1). 13–16. 10 indexed citations
14.
Nab, Henk, Huub M. Kluck, Emiel J. Rutgers, J.W.W. Coebergh, & Wim C.J. Hop. (1995). Long-term prognosis of breast cancer: An analysis of 462 patients in a general hospital in south east Netherlands. European Journal of Surgical Oncology. 21(1). 42–46. 8 indexed citations
15.
Nab, Henk, et al.. (1995). Striking changes in smoking behaviour and lung cancer incidence by histological type in Southeast Netherlands, 1960–1991. European Journal of Cancer. 31(6). 949–952. 54 indexed citations
16.
Nab, Henk, et al.. (1994). Is the peak in breast cancer incidence in sight? A study conducted in the southeastern Netherlands. European Journal of Cancer. 30(1). 50–52. 9 indexed citations
17.
Nab, Henk, Wim C.J. Hop, M.A. Crommelin, et al.. (1994). Changes in long term prognosis for breast cancer in a Dutch cancer registry. BMJ. 309(6947). 83–86. 25 indexed citations
18.
Nab, Henk, Adri C. Voogd, M.A. Crommelin, et al.. (1993). Breast cancer in the southeastern Netherlands, 1960–1989: Trends in incidence and mortality. European Journal of Cancer. 29(11). 1557–1559. 22 indexed citations
19.
Nab, Henk, et al.. (1992). Comparison of Digital and Conventional Mammography: A ROC Study of 270 Mammograms. Medical Informatics. 17(2). 125–131. 26 indexed citations
20.
Nab, Henk, et al.. (1990). [Digital mammography is very useful in mass screening of breast cancer].. PubMed. 134(49). 2383–7. 1 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by A. Nzeusseu Toukap Breakdown of academic impact, for papers by DT Boumpas Breakdown of academic impact, for papers by F M Lai Breakdown of academic impact, for papers by Bozena Möller Breakdown of academic impact, for papers by K. D. Watson Breakdown of academic impact, for papers by Larissa Lisnevskaia Breakdown of academic impact, for papers by Allen R. Hendricks Breakdown of academic impact, for papers by David Musselman Breakdown of academic impact, for papers by A. Krabben Breakdown of academic impact, for papers by Jared Hassler
Rankless by CCL
2026